Skip to main content
Top
Published in: Italian Journal of Pediatrics 1/2023

Open Access 01-12-2023 | Mycobacterium Tuberculosis | Research

Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients

Authors: Irum Gul, Taj Ali Khan, Noor ul Akbar, Naila Gul, Rehman Ali, Shahid Niaz Khan

Published in: Italian Journal of Pediatrics | Issue 1/2023

Login to get access

Abstract

Background

Chronic Granulomatous Disease (CGD) is a primary immunodeficiency that causes susceptibility to recurrent fungal and bacterial infections. The CYBB gene encodes gp91phox component of the Phagocytic Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and specifically, X-linked CGD is caused by mutations in the CYBB gene, located on the X chromosome. The aim of the study was to characterize functional and genetic mutations in X-linked CGD.

Methods

Functional analysis was conducted on the whole blood of seventeen male individuals who were suspected to have X-linked chronic granulomatous disease (CGD). Flow cytometry was employed to assess the capacity of NADPH oxidase, measuring both H2O2 production and gp91phox protein expression in neutrophils. Additionally, DNA Sanger sequencing was performed for genetic analysis. The pathogenicity of novel mutations was assessed by pathogenicity prediction tools.

Result

Among the seventeen patients evaluated, five patients (P1, P2, P3, P4, and P5) displayed impaired H2O2 production by their neutrophils upon stimulation with Phorbol myristate acetate (PMA), accompanied by abnormal gp91phox expression. DNA sequencing of the CYBB gene identified specific mutations in each patient. In P1 and P2 (previously reported cases), a hemizygous missense mutation, c.925G > A/p.E309K was identified. In P3 and P4 (novel cases), hemizygous nonsense mutations, c.216T > A/p.C72X were found. Lastly, in P5 (also a novel case), a hemizygous missense mutation, c.732T > G/p.C244W was detected. These mutations reside in exons 9,3 and 7 of the CYBB gene, respectively.

Conclusions

The current study contributes to the understanding of the clinical and genetic spectrum associated with X-linked chronic granulomatous disease (CGD). It highlights the significance of early diagnosis in CGD and emphasizes the importance of lifelong prophylaxis to prevent severe infections.
Appendix
Available only for authorised users
Literature
1.
go back to reference de Oliveira-Junior EB, Bustamante J, Newburger PE, Condino-Neto A. The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand J Immunol. 2011;73(5):420–7.PubMedCrossRef de Oliveira-Junior EB, Bustamante J, Newburger PE, Condino-Neto A. The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand J Immunol. 2011;73(5):420–7.PubMedCrossRef
2.
3.
go back to reference Deffert C, Cachat J, Krause KH. Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections. Cell Microbiol. 2014;16(8):1168–78.PubMedCrossRef Deffert C, Cachat J, Krause KH. Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections. Cell Microbiol. 2014;16(8):1168–78.PubMedCrossRef
4.
go back to reference El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, Braut-Boucher F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med. 2009;41(4):217–25.PubMedPubMedCentralCrossRef El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, Braut-Boucher F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med. 2009;41(4):217–25.PubMedPubMedCentralCrossRef
5.
go back to reference Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000;12(2):201–10.PubMedCrossRef Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000;12(2):201–10.PubMedCrossRef
6.
go back to reference Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine. 2000;79(3):170–200.PubMedCrossRef Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine. 2000;79(3):170–200.PubMedCrossRef
7.
go back to reference Holland SM. Chronic granulomatous disease. Hematol Oncol Clin N Am. 2013;27(1):89–99. viii.CrossRef Holland SM. Chronic granulomatous disease. Hematol Oncol Clin N Am. 2013;27(1):89–99. viii.CrossRef
8.
go back to reference Khan TA, Kalsoom K, Iqbal A, Asif H, Rahman H, Farooq SO, et al. A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections. Microb Pathog. 2016;100:163–9.PubMedCrossRef Khan TA, Kalsoom K, Iqbal A, Asif H, Rahman H, Farooq SO, et al. A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections. Microb Pathog. 2016;100:163–9.PubMedCrossRef
9.
go back to reference Stasia MJ, Bordigoni P, Floret D, Brion JP, Bost-Bru C, Michel G, et al. Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease. Hum Genet. 2005;116(1–2):72–82.PubMedCrossRef Stasia MJ, Bordigoni P, Floret D, Brion JP, Bost-Bru C, Michel G, et al. Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease. Hum Genet. 2005;116(1–2):72–82.PubMedCrossRef
10.
go back to reference Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27(1):101–8.PubMedCrossRef Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27(1):101–8.PubMedCrossRef
11.
go back to reference Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149(3):410–23.PubMedPubMedCentralCrossRef Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149(3):410–23.PubMedPubMedCentralCrossRef
12.
go back to reference Hasui M, Hirabayashi Y, Kobayashi Y. Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood. J Immunol Methods. 1989;117(1):53–8.PubMedCrossRef Hasui M, Hirabayashi Y, Kobayashi Y. Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood. J Immunol Methods. 1989;117(1):53–8.PubMedCrossRef
13.
go back to reference Köker MY, Sanal O, De Boer M, Tezcan I, Metin A, Ersoy F, et al. Mutations of chronic granulomatous disease in turkish families. Eur J Clin Invest. 2007;37(7):589–95.PubMedCrossRef Köker MY, Sanal O, De Boer M, Tezcan I, Metin A, Ersoy F, et al. Mutations of chronic granulomatous disease in turkish families. Eur J Clin Invest. 2007;37(7):589–95.PubMedCrossRef
14.
go back to reference Wada T, Muraoka M, Toma T, Imai T, Shigemura T, Agematsu K, et al. Rapid detection of intracellular p47phox and p67phox by flow cytometry; useful screening tests for chronic granulomatous disease. J Clin Immunol. 2013;33(4):857–64.PubMedCrossRef Wada T, Muraoka M, Toma T, Imai T, Shigemura T, Agematsu K, et al. Rapid detection of intracellular p47phox and p67phox by flow cytometry; useful screening tests for chronic granulomatous disease. J Clin Immunol. 2013;33(4):857–64.PubMedCrossRef
15.
16.
go back to reference Girotto G, Scheffer DI, Morgan A, Vozzi D, Rubinato E, Di Stazio M, et al. PSIP1/LEDGF: a new gene likely involved in sensorineural progressive hearing loss. Sci Rep. 2015;5:18568.PubMedPubMedCentralCrossRef Girotto G, Scheffer DI, Morgan A, Vozzi D, Rubinato E, Di Stazio M, et al. PSIP1/LEDGF: a new gene likely involved in sensorineural progressive hearing loss. Sci Rep. 2015;5:18568.PubMedPubMedCentralCrossRef
17.
go back to reference Schiemann AH, Stowell KM. Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia. Br J Anaesth. 2016;117(1):124–8.PubMedPubMedCentralCrossRef Schiemann AH, Stowell KM. Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia. Br J Anaesth. 2016;117(1):124–8.PubMedPubMedCentralCrossRef
18.
go back to reference Martins-Pinheiro M, Lima WC, Asif H, Oller CA, Menck CF. Evolutionary and Functional Relationships of the dha regulon by genomic context analysis. PLoS ONE. 2016;11(3):e0150772.PubMedPubMedCentralCrossRef Martins-Pinheiro M, Lima WC, Asif H, Oller CA, Menck CF. Evolutionary and Functional Relationships of the dha regulon by genomic context analysis. PLoS ONE. 2016;11(3):e0150772.PubMedPubMedCentralCrossRef
19.
go back to reference Magnani F, Nenci S, Millana Fananas E, Ceccon M, Romero E. Crystal structures and atomic model of NADPH oxidase. 2017;114(26):6764–9. Magnani F, Nenci S, Millana Fananas E, Ceccon M, Romero E. Crystal structures and atomic model of NADPH oxidase. 2017;114(26):6764–9.
20.
go back to reference Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779–815.PubMedCrossRef Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779–815.PubMedCrossRef
21.
go back to reference Esquivel-Solís H, Quiñones-Falconi F, Zarain-Herzberg A, Amieva-Fernández RI, López-Vidal Y. Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis. Clin Exp Immunol. 2009;158(1):45–54.PubMedPubMedCentralCrossRef Esquivel-Solís H, Quiñones-Falconi F, Zarain-Herzberg A, Amieva-Fernández RI, López-Vidal Y. Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis. Clin Exp Immunol. 2009;158(1):45–54.PubMedPubMedCentralCrossRef
22.
go back to reference Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(3):246–65.PubMedPubMedCentralCrossRef Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(3):246–65.PubMedPubMedCentralCrossRef
23.
go back to reference Ishibashi F, Nunoi H, Endo F, Matsuda I, Kanegasaki S. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Hum Genet. 2000;106(5):473–81.PubMedCrossRef Ishibashi F, Nunoi H, Endo F, Matsuda I, Kanegasaki S. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Hum Genet. 2000;106(5):473–81.PubMedCrossRef
24.
go back to reference n den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the european experience. PLoS ONE. 2009;4(4):e5234.PubMedPubMedCentralCrossRef n den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the european experience. PLoS ONE. 2009;4(4):e5234.PubMedPubMedCentralCrossRef
25.
go back to reference Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine. 2000;79(3):155–69.PubMedCrossRef Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine. 2000;79(3):155–69.PubMedCrossRef
26.
go back to reference Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med. 2006;203(7):1745–59.PubMedPubMedCentralCrossRef Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med. 2006;203(7):1745–59.PubMedPubMedCentralCrossRef
27.
go back to reference Al-Hammadi S, Yahya AM, Al-Amri A, Shibli A, Balhaj GB, Tawil MI, et al. Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an infant with X-Linked recessive mendelian susceptibility to Mycobacterial Disease due to a variant of chronic Granulomatous Disease. Front Pead. 2021;9:687538.CrossRef Al-Hammadi S, Yahya AM, Al-Amri A, Shibli A, Balhaj GB, Tawil MI, et al. Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an infant with X-Linked recessive mendelian susceptibility to Mycobacterial Disease due to a variant of chronic Granulomatous Disease. Front Pead. 2021;9:687538.CrossRef
28.
go back to reference Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç S, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 turkish patients. J Allergy Clin Immunol. 2013;132(5):1156–63e5.PubMedCrossRef Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç S, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 turkish patients. J Allergy Clin Immunol. 2013;132(5):1156–63e5.PubMedCrossRef
29.
go back to reference Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 iranian patients with chronic granulomatous disease. J Clin Immunol. 2011;31(5):792–801.PubMedCrossRef Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 iranian patients with chronic granulomatous disease. J Clin Immunol. 2011;31(5):792–801.PubMedCrossRef
30.
go back to reference Agudelo-Flórez P, Prando-Andrade CC, López JA, Costa-Carvalho BT, Quezada A, Espinosa FJ, et al. Chronic granulomatous disease in latin american patients: clinical spectrum and molecular genetics. Pediatr Blood Cancer. 2006;46(2):243–52.PubMedCrossRef Agudelo-Flórez P, Prando-Andrade CC, López JA, Costa-Carvalho BT, Quezada A, Espinosa FJ, et al. Chronic granulomatous disease in latin american patients: clinical spectrum and molecular genetics. Pediatr Blood Cancer. 2006;46(2):243–52.PubMedCrossRef
31.
go back to reference Morel F. [Molecular aspects of chronic granulomatous disease. “the NADPH oxidase complex”]. Bull de l’Academie nationale de Med. 2007;191(2):377–. – 90; discussion 90 – 2. Morel F. [Molecular aspects of chronic granulomatous disease. “the NADPH oxidase complex”]. Bull de l’Academie nationale de Med. 2007;191(2):377–. – 90; discussion 90 – 2.
32.
go back to reference Hussain W, Batool A, Ahmed TA, Bashir MM. Severe combined immunodeficiency due to adenosine deaminase deficiency. JPMA The Journal of the Pakistan Medical Association. 2012;62(3):297–9.PubMed Hussain W, Batool A, Ahmed TA, Bashir MM. Severe combined immunodeficiency due to adenosine deaminase deficiency. JPMA The Journal of the Pakistan Medical Association. 2012;62(3):297–9.PubMed
33.
go back to reference Khan MO, Memon AI, Zubairi AB, Imam AA. Undetected common variable immune deficiency in a young adult of pakistani descent. J Ayub Med Coll Abbottabad. 2011;23(1):165–6.PubMed Khan MO, Memon AI, Zubairi AB, Imam AA. Undetected common variable immune deficiency in a young adult of pakistani descent. J Ayub Med Coll Abbottabad. 2011;23(1):165–6.PubMed
34.
go back to reference Saleem AF, Ali Khawaja RD, Shaikh AS, Ali SA, Mehdi Zaidi AK. Severe combined immune deficiency syndrome. J Coll Physicians Surgeons–Pakistan : JCPSP. 2013;23(8):570–3. Saleem AF, Ali Khawaja RD, Shaikh AS, Ali SA, Mehdi Zaidi AK. Severe combined immune deficiency syndrome. J Coll Physicians Surgeons–Pakistan : JCPSP. 2013;23(8):570–3.
35.
go back to reference von Goessel H, Hossle JP, Seger R, Gungor T. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene. Exp Hematol. 2006;34(4):528–35.CrossRef von Goessel H, Hossle JP, Seger R, Gungor T. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene. Exp Hematol. 2006;34(4):528–35.CrossRef
36.
go back to reference Bionda C, Li XJ, van Bruggen R, Eppink M, Roos D, Morel F, et al. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet. 2004;115(5):418–27.PubMedCrossRef Bionda C, Li XJ, van Bruggen R, Eppink M, Roos D, Morel F, et al. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet. 2004;115(5):418–27.PubMedCrossRef
37.
go back to reference Marciano BE, Wesley R, De Carlo ES, Anderson VL, Barnhart LA, Darnell D, et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis. 2004;39(5):692–9.PubMedCrossRef Marciano BE, Wesley R, De Carlo ES, Anderson VL, Barnhart LA, Darnell D, et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis. 2004;39(5):692–9.PubMedCrossRef
38.
go back to reference Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348(24):2416–22.PubMedCrossRef Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348(24):2416–22.PubMedCrossRef
39.
go back to reference Weening RS, Kabel P, Pijman P, Roos D. Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J Pediatr. 1983;103(1):127–30.PubMedCrossRef Weening RS, Kabel P, Pijman P, Roos D. Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J Pediatr. 1983;103(1):127–30.PubMedCrossRef
40.
go back to reference Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162(3):723–6.PubMedCrossRef Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162(3):723–6.PubMedCrossRef
41.
go back to reference Oikonomopoulou Z, Shulman S, Mets M, Katz B. Correction to: chronic granulomatous disease: an updated experience, with emphasis on newly recognized features. 2022;42(7):1420. Oikonomopoulou Z, Shulman S, Mets M, Katz B. Correction to: chronic granulomatous disease: an updated experience, with emphasis on newly recognized features. 2022;42(7):1420.
42.
go back to reference Gunderman L, Brown J, Chaudhury S, O’Gorman M, Fuleihan R, Khanolkar A. Co-occurring X-Linked agammaglobulinemia and X-Linked chronic Granulomatous Disease: two isolated pathogenic variants in one patient. 2023;11(3). Gunderman L, Brown J, Chaudhury S, O’Gorman M, Fuleihan R, Khanolkar A. Co-occurring X-Linked agammaglobulinemia and X-Linked chronic Granulomatous Disease: two isolated pathogenic variants in one patient. 2023;11(3).
43.
go back to reference Gao XF, Yang ZW, Li J. Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review. Int J Infect Dis. 2011;15(9):e594–600.PubMedCrossRef Gao XF, Yang ZW, Li J. Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review. Int J Infect Dis. 2011;15(9):e594–600.PubMedCrossRef
44.
go back to reference Khan TA, Schimke LF, Amaral EP, Ishfaq M, Barbosa Bonfim CC, Rahman H, et al. Interferon-gamma reduces the proliferation of M. tuberculosis within macrophages from a patient with a novel hypomorphic NEMO mutation. Pediatr Blood Cancer. 2016;63(10):1863–6.PubMedCrossRef Khan TA, Schimke LF, Amaral EP, Ishfaq M, Barbosa Bonfim CC, Rahman H, et al. Interferon-gamma reduces the proliferation of M. tuberculosis within macrophages from a patient with a novel hypomorphic NEMO mutation. Pediatr Blood Cancer. 2016;63(10):1863–6.PubMedCrossRef
Metadata
Title
Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients
Authors
Irum Gul
Taj Ali Khan
Noor ul Akbar
Naila Gul
Rehman Ali
Shahid Niaz Khan
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2023
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-023-01496-7

Other articles of this Issue 1/2023

Italian Journal of Pediatrics 1/2023 Go to the issue